Blocking both E-selectin and P-selectin inhibits endotoxin-induced leukocyte infiltration into the eye.
The initial contact between leukocytes and the vascular endothelium at sites of inflammation is mediated by selectins. The purpose of this study was to investigate the role of the two selectins expressed on the vascular endothelium, E-selectin and P-selectin, in the pathogenesis of endotoxin-induced uveitis. Endotoxin-induced uveitis was produced in female C3H/HeN mice using Salmonella typhimurium endotoxin injected into one hind footpad. At the time of endotoxin injection mice were treated with an intraperitoneal injection of a monoclonal antibody against E-selectin or P-selectin, a combination of both anti-selectin antibodies, or isotype-matched control antibodies. In a second set of experiments, antibody treatment was administered 6 hr after endotoxin injection, when inflammatory cells are already entering the eye. Ocular inflammation was graded histologically by a masked observer. When administered at the time of endotoxin injection, anti-P-selectin antibody decreased ocular inflammation by 37% compared to control animals (P = 0.05). There was no statistical decrease in ocular inflammation in animals treated with anti-E-selectin antibody. The combination of anti-P-selectin and anti-E-selectin antibodies decreased infiltrating inflammatory cells by 61% (P < 0.01). When treatment was delayed until 6 hr after endotoxin injection, the combination of anti-P-selectin and anti-E-selectin antibodies again decreased ocular inflammation by 60% (P < 0.01). Immunohistochemical staining showed decreased ICAM-1 expression in the eyes of animals treated with the combination of anti-P-and anti-E-selectin antibodies. Blocking both P-selectin and E-selectin resulted in a significant decrease in endotoxin-induced intraocular inflammation.
Whitcup
S M
SM
National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Kozhich
A T
AT
Lobanoff
M
M
Wolitzky
B A
BA
Chan
C C
CC
D000818:Animals; D000906:Antibodies / Q000494:pharmacology / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use; D004195:Disease Models, Animal; D019040:E-Selectin / Q000276:immunology / Q000502:physiology*; D004731:Endotoxins; D005123:Eye / Q000276:immunology; D005260:Female; D007150:Immunohistochemistry; D018799:Intercellular Adhesion Molecule-1 / Q000502:physiology; D051379:Mice; D008809:Mice, Inbred C3H; D009504:Neutrophils / Q000187:drug effects; D019007:P-Selectin / Q000276:immunology / Q000502:physiology*; D014605:Uveitis / Q000139:chemically induced* / Q000517:prevention & control*
D000906:Antibodies; D000911:Antibodies, Monoclonal; D019040:E-Selectin; D004731:Endotoxins; D019007:P-Selectin; D018799:Intercellular Adhesion Molecule-1